Emcure Pharmaceuticals fundamental analysis

EMCURE

1438

76.20 (-5.03%)
Last updated on 13 Mar, 2026 | 15:51 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Emcure Pharmaceuticals Fundamentals

P/E Ratio

34.02

P/B Ratio

5.95

Div. Yield

0.19

Sector P/E

61.58

Sector P/B

2.71

Sec. Div. Yield

0.58

Emcure Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 34.02, compared to the sector average of 61.58. Its P/B Ratio stands at 5.95, while the sector’s is 2.71. In terms of returns, the stock offers a Dividend Yield of 0.19%, which is than the sector’s 0.58%.

Emcure Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Emcure Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost